Daiichi Sankyo Company, Limited (DSKYF)
OTCMKTS · Delayed Price · Currency is USD
24.38
+1.86 (8.24%)
At close: Nov 28, 2025
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $45.8 billion as of November 28, 2025. Its market cap has decreased by -23.90% in one year.
Market Cap
45.80B
Enterprise Value
43.62B
Revenue
13.37B
Ranking
n/a
PE Ratio
24.22
Stock Price
$24.38
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 45.80B, an increase of 1,465.21%. That is a compound annual growth rate of 14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 45.80B | -12.19% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | 66.36B | 54.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 566.42M |
| Glass House Brands | 508.04M |
| American Oncology Network | 429.20M |
| CytoDyn | 416.43M |
| Northwest Biotherapeutics | 389.02M |
| Silence Therapeutics | 323.08M |
| Nika Pharmaceuticals | 259.96M |